Skip to main content
OpenTrials
Completed

NCT Number: NCT02714933

Thoracic MRI Imaging in Children

The aim of this study is to compare a new Magnetic Resonance Imaging (MRI)protocol, including a new MRI sequence for visualization of lung parenchyma, to computed tomography as the gold standard for the evaluation of thoracic region in children.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 year–16 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Necker hospital

Paris, 75015, France

About this study

The potential effects of ionizing radiation are of particular concern in children. Exposure to ionizing radiation of medical origin is responsible for an increased risk of brain tumors and hematopoietic lineage in children. It is therefore necessary to find alternative to the use of irradiating imaging examinations. Currently, computed tomography (CT) is the gold standard in the study of lung diseases and is used in children deepening of standard radiography in acute or chronic situations, sometimes requiring iterative controls. Chest CT delivers a radiation dose equivalent to up to 500 days of natural exposure. Moreover, for the analysis of mediastinal and vascular structures it requires an intravenous injection of iodinated contrast, potentially source of nephrotoxicity and anaphylactic reactions. Recently, new developments in Magnetic Resonance Imaging (MRI) have shown interest in the study of lung diseases when they are responsible for filling of aeric structures (mucoid impaction in cystic fibrosis, alveolar filling in infectious process and tumor) and in the analysis of vascular and mediastinal structures and heart. However, the aerated lung presenting a very low density of protons, and MRI being particularly sensitive to artifacts from cardiac and respiratory movements, sequences currently used in MRI remain insufficient in the analysis of pulmonary structures and pathologic conditions not filling aeric spaces (bronchial, cystic, emphysematous or interstitial diseases). The aim of this study is to test in clinical practice, a new MRI sequence for visualizing lung parenchyma, 3D zero Time Echo (Advanced ZTE) and to propose a protocol combining several MRI sequences without injection as an alternative to chest CT with or without contrast medium injection in childhood.

The proposed hypotheses are :

  • MRI sequence Advanced ZTE allows visualization of normal and pathological lung parenchymal structures.
  • A complete MRI protocol, without injection, including this sequence to those already used in clinical practice could replace the enhanced CT in most pediatric indications.

The principal objective of the study is to evaluate the Advanced ZTE sequence in the visualization of lung parenchyma structures in comparison to CT scan in lung window as gold standard.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children, aged 6-16 years,
  • Introducing one or more clinical indications for performing a chest CT with and without contrast injection within 1 day to 3 months.
  • Monitoring at the Necker Hospital.
  • Signature of consent by a holder of parental authority.
  • Patient affiliated or beneficiary of a social security

Exclusion criteria

  • Contraindication to performing MRI: claustrophobia, cochlear implant, nerve stimulator, pacemaker implant or intra-cardiac metallic foreign body, chest or eye.
  • Need for MRI under sedation or general anesthesia.
  • Indication of an emergency CT within less than 12 hours (especially suspected pulmonary embolism).

Treatment and study plan

MRI sequence Advanced ZTE

Other

Evaluation of the image quality in terms of visualization of anatomical structures of the lung parenchyma in safe zone by a new imaging method of the pulmonary parenchyma by MRI (Advanced ZTE sequence).

Primary outcomes

  1. Score on the Likert Scale of visual image quality

    Time frame: 3 months

    Evaluation MRI sequence Advanced ZTE in terms of image quality and visualization of the pulmonary parenchyma

Secondary outcomes

  1. Noise index

    Time frame: 3 months

    Quantitative evaluation for the quality of the image obtained by the Advanced ZTE sequence

  2. Contrast index

    Time frame: 3 months

    Quantitative evaluation for the quality of the image obtained by the Advanced ZTE sequence

  3. visual score of image quality in CT in parenchyma window in safe area

    Time frame: 3 months

  4. visual score of image quality in CT in pulmonary parenchyma lesions

    Time frame: 3 months

  5. visual score of image quality in MRI in parenchyma window in safe area

    Time frame: 3 months

  6. visual score of image quality in MRI in pulmonary parenchyma lesions

    Time frame: 3 months

  7. visual score of image quality in CT viewing the normal structures of the mediastinum

    Time frame: 3 months

  8. visual score of image quality in CT viewing the mediastinal and pleural lesions or abnormalities

    Time frame: 3 months

  9. visual score of image quality in MRI viewing the normal structures of the mediastinum

    Time frame: 3 months

  10. visual score of image quality in MRI viewing the mediastinal and pleural lesions or abnormalities

    Time frame: 3 months

  11. Number of participants with adverse events in CT

    Time frame: 3 months

  12. Number of participants with adverse events in MRI

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

  • URC-CIC Paris Descartes Necker Cochin

Registry information

Official study title

Thoracic Imaging in Children With Neither Irradiation Nor Injection, by a New MRI Protocol Including Advanced Zero Time Echo (ZTE)

Acronym: ImagINI-CHEST

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Mar 22, 2016
Registry last updated
Sep 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.